Literature DB >> 6587438

Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries.

M Nakajima, N Toda.   

Abstract

Treatment with prostaglandin (PG) D2 in concentrations (10(-8) to 10(-7) M) insufficient to alter the basal tone potentiated the contractile response of helical strips of dog mesenteric arteries to transmural electrical stimulation but did not influence the response to norepinephrine. The potentiating effect of PGD2 was not prevented by treatment with diphloretin phosphate, a PG antagonist, whereas contractions of dog cerebral arteries induced by PGD2 were suppressed. The 3H-overflow evoked by transmural stimulation in superfused mesenteric arterial strips previously soaked in 3H-norepinephrine containing media was significantly increased in PGD2. It is concluded that PGD2 increases the stimulation-evoked release of norepinephrine from adrenergic nerves innervating the arterial wall. PGD2 appears to act differently on receptive sites responsible for increasing the release of norepinephrine and for producing arterial contraction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587438     DOI: 10.1016/0090-6980(84)90199-0

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  6 in total

1.  Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.

Authors:  G Molderings; B Malinowska; E Schlicker
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

2.  Intra- and extraluminally-applied acetylcholine on the vascular tone or the response to transmural stimulation in dog isolated mesenteric arteries.

Authors:  N Toda; S Inoue; H Okunishi; T Okamura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

3.  Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries.

Authors:  T Okamura; M Nakajima; N Toda
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

5.  Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

Authors:  G J Molderings; E Colling; J Likungu; J Jakschik; M Göthert
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

Review 6.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.